MILESTONE PHARMACEUTICALS IN's ticker is MIST and the CUSIP is 59935V107. A total of 31 filers reported holding MILESTONE PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $1,552,000 | -38.2% | 267,997 | -28.5% | 0.00% | – |
| Q4 2020 | $2,512,000 | -40.5% | 374,957 | -35.0% | 0.00% | – |
| Q3 2020 | $4,221,000 | +74.4% | 576,703 | -9.9% | 0.00% | – |
| Q2 2020 | $2,420,000 | +124.9% | 640,186 | +9.5% | 0.00% | – |
| Q1 2020 | $1,076,000 | -94.8% | 584,615 | -54.6% | 0.00% | -100.0% |
| Q4 2019 | $20,597,000 | -8.5% | 1,286,507 | -1.1% | 0.00% | 0.0% |
| Q3 2019 | $22,501,000 | -36.2% | 1,300,646 | +0.1% | 0.00% | -40.0% |
| Q2 2019 | $35,294,000 | – | 1,299,946 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,425,737 | $22,293,000 | 3.44% |
| Lion Point Capital, LP | 1,557,233 | $11,186,000 | 2.46% |
| ACUTA CAPITAL PARTNERS, LLC | 597,026 | $5,487,000 | 2.36% |
| Ikarian Capital, LLC | 855,616 | $7,863,000 | 1.57% |
| GREAT POINT PARTNERS LLC | 674,656 | $6,200,000 | 1.49% |
| Bleichroeder LP | 512,500 | $4,710,000 | 0.98% |
| RTW INVESTMENTS, LP | 4,315,102 | $39,656,000 | 0.91% |
| Novo Holdings A/S | 2,000,000 | $18,380,000 | 0.88% |
| Paradigm Biocapital Advisors LP | 634,211 | $5,828,000 | 0.78% |
| Ikarian Capital, LLC | 338,000 | $3,107,000 | 0.62% |